Key facts
- This page summarizes Dennis J. Carlo PhD's Form 4 filing for Adamis Pharmaceuticals Corp.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2022, 16:07.
Dennis J. Carlo PhD - 25 May 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp
- Reporting relationship
- Former President & CEO
- Issuer ticker
- N/A
- Reported as of
- 25 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2022, 16:07:12 UTC
- Prior SEC filing
- 22 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David C. Benedicto, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dennis J. Carlo PhD filed Form 4 for Adamis Pharmaceuticals Corp on 27 May 2022.
Change
- Previous filing in this sequence was filed on 22 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADMP
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +250,000
- Change %
- +87%
- Price
- Shares after
- 535,867
- Date
- 25 May 2022
- Ownership
- Direct
- Footnotes
- F1
ADMP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 150,709
- Date
- 25 May 2022
- Ownership
- By Dennis and Allison Carlo Joint Living Trust
ADMP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,883
- Date
- 25 May 2022
- Ownership
- By A.Carlo as custodian for Child
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADMP
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -250,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Dennis J. Carlo PhD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs.
Footnote F2
On March 1, 2017, the reporting person was granted 250,000 Restricted Stock Units. On May 25, 2022 all of these Restricted Stock Units were fully vested.